Cargando…

Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial

BACKGROUND: Persons with diabetes are at high risk of developing diabetic kidney disease (DKD), which is associated with high morbidity and mortality. Current drug therapies for DKD, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are not entirely s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ping, Chen, Yiping, Liu, Jianping, Hong, Jing, Deng, Yueyi, Yang, Fang, Jin, Xiuping, Gao, Jing, Li, Jing, Fang, Hui, Liu, Geling, Shi, Liping, Du, Jinhang, Li, Yang, Yan, Meihua, Wen, Yumin, Yang, Wenying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418676/ https://www.ncbi.nlm.nih.gov/pubmed/25938778 http://dx.doi.org/10.1371/journal.pone.0126027

Ejemplares similares

Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats
por: Zhao, TingTing, et al.
Publicado: (2016)

Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease
por: Yang, Xin, et al.
Publicado: (2016)

Effect of Tangshen formula on the remodeling of small intestine and colon in Zucker diabetic fatty rats
por: Yang, Xin, et al.
Publicado: (2023)

Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial
por: Yan, Meihua, et al.
Publicado: (2016)

Tangshen Formula Attenuates Colonic Structure Remodeling in Type 2 Diabetic Rats
por: Chen, Pengmin, et al.
Publicado: (2017)

Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression
por: Zhao, Hailing, et al.
Publicado: (2017)

Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice
por: Kong, Qin, et al.
Publicado: (2016)

Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice
por: Liu, Peng, et al.
Publicado: (2018)

Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway
por: Wang, Yan, et al.
Publicado: (2019)

Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-pyroptotic Effects via the TXNIP-NLRP3-GSDMD Axis
por: Li, Nan, et al.
Publicado: (2021)

Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula)
por: Zhang, Haojun, et al.
Publicado: (2011)

Mechanism of tangshen formula in treating diabetic nephropathy revealed by network pharmacology approach
por: Quan, Na, et al.
Publicado: (2021)

Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in db/db Mice Using Cytokine Antibody Array
por: Fan, Xue Mei, et al.
Publicado: (2018)

Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial
por: Jin, De, et al.
Publicado: (2019)

A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease
por: Jin, Zhaohui, et al.
Publicado: (2020)

Tangshen Formula Improves Diabetes-Associated Myocardial Fibrosis by Inhibiting TGF-β/Smads and Wnt/β-Catenin Pathways
por: Hu, Lin, et al.
Publicado: (2021)

Protective Role of Tangshen Formula on the Progression of Renal Damage in db/db Mice by TRPC6/Talin1 Pathway in Podocytes
por: Wang, Qian, et al.
Publicado: (2020)

Characterization of Codonopsis pilosula subsp. tangshen plastome and comparative analysis of Codonopsis species
por: Yue, Jingwen, et al.
Publicado: (2022)

TMT-Based Proteomic Analysis of Continuous Cropping Response in Codonopsis tangshen Oliv.
por: Jiang, Xiaogang, et al.
Publicado: (2023)

Codonopsis tangshen Oliv. Amelioration Effect on Diabetic Kidney Disease Rats Induced by High Fat Diet Feeding Combined with Streptozotocin
por: Lu, Xian-Yuan, et al.
Publicado: (2018)

A randomized, double-blind, placebo-controlled multicenter clinical trial of Xiehuang Jiejing granule in the treatment of cough variant asthma in children
por: Qiao, Yi-Na, et al.
Publicado: (2022)

Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Zhang, Jing-Hao, et al.
Publicado: (2022)

Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial
por: Zhao, Jing, et al.
Publicado: (2020)

Transcriptome analysis provides novel insights into the soil amendments induced response in continuously cropped Codonopsis tangshen
por: Zhou, Wuxian, et al.
Publicado: (2022)

The role of Erzhi Tiangui formula in expected poor ovarian responders undergoing in vitro fertilization-embryo transfer: A multicenter, randomized, double-blind, placebo-controlled trial
por: Han, Qiao-Song, et al.
Publicado: (2023)

The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing In Vitro Fertilization-Embryo Transfer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Song, Jing-Yan, et al.
Publicado: (2021)

Efficacy of Chuanxiong Ding Tong Herbal Formula Granule in the Treatment and Prophylactic of Migraine Patients: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial
por: Fu, Caihong, et al.
Publicado: (2012)

Efficacy and safety of vibrating capsule for functional constipation (VICONS): A randomised, double-blind, placebo-controlled, multicenter trial
por: Zhu, Jia-Hui, et al.
Publicado: (2022)

Transcriptomic Analysis Provides Novel Insights into the Heat Stress-Induced Response in Codonopsis tangshen
por: Jiang, Xiaogang, et al.
Publicado: (2023)

An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules
por: Han, Mei, et al.
Publicado: (2019)

Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
por: Zheng, Yujiao, et al.
Publicado: (2022)

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
por: Xu, Rui-Hua, et al.
Publicado: (2017)

Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Wang, Qin, et al.
Publicado: (2020)

Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial
por: Sun, Yulin, et al.
Publicado: (2022)

Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub‐cohort analysis of a phase III, randomized, double‐blind, placebo‐controlled trial
por: Peng, Li Hua, et al.
Publicado: (2022)

Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Zhu, Xiao-Jun, et al.
Publicado: (2013)

Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial
por: Qiu, Lei, et al.
Publicado: (2021)

Tangshen Formula Treatment for Diabetic Kidney Disease by Inhibiting Racgap1-stata5-Mediated Cell Proliferation and Restoring miR-669j-Arntl-Related Circadian Rhythm
por: Wang, Xiuying, et al.
Publicado: (2018)

Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
por: Zheng, Ying, et al.
Publicado: (2017)

A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study of the Effects of Tongxinluo Capsules in Acute Coronary Syndrome Patients with High On-Treatment Platelet Reactivity
por: Zhang, Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nqfflstqo4un05vqucoro2t8md